Krystal Biotech, Inc
Pittsburgh, PA 15203
412-586-5830
At a Glance
- Primary NAICS Code
- 325412
- NAICS
- 325412
- Headquarters
- Pittsburgh, PA
- UEI
- H5VRRQJHRBL3
- CAGE
- 8BC06
- Founded
- 2017
- Legal name
- KRYSTAL BIOTECH, INC.
- County
- Allegheny County
- Congressional district
- 12
About
Krystal Biotech, Inc. is a commercial-stage biotechnology company developing and commercializing genetic medicines for patients with rare diseases using a proprietary redosable HSV-1 vector platform. The company operates integrated manufacturing facilities and has an approved gene therapy product, VYJUVEK, for dystrophic epidermolysis bullosa.
Capabilities & Markets
Directory supply chains
Products
Service offerings
Manufacturing processes
End markets served
Classification
NAICS Codes
Compliance & Registrations
Registration IDs
- UEI
- H5VRRQJHRBL3
- CAGE
- 8BC06
Related Manufacturers
PeriphaGenPeriphaGen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector for neurologic disease. The company has developed a replication defective HSV-1 vector platform called 'Neuronal Therapeutics' (NET) for delivery of tissue specific gene expression in sensory neurons from a simple skin administration. PeriphaGen's lead product, PGN-503, is designed to prevent or treat peripheral neuropathy in patients receiving chemotherapy.PITTSBURGH, PA
Franklin BiolabsFranklin Biolabs is a preclinical Contract Research Organization (CRO) accelerating the development of genetic medicines and biologics. The company specializes in AAV vector manufacturing, process development, large-scale production, analytical testing, preclinical translational services, toxicology, and bioanalytical services for cell and gene therapies.325414PHILADELPHIA, PA
CSL BehringCSL Behring is a global biotherapeutics leader that discovers, develops, and delivers innovative therapies for people living with rare and serious diseases. The company uses plasma fractionation, recombinant protein technology, and cell and gene therapy to manufacture treatments for immunology, hematology, cardiovascular, metabolic, respiratory, and transplant therapeutic areas.KING OF PRUSSIA, PA
Ori BiotechOri Biotech is a London- and Philadelphia-based leader in cell and gene therapy (CGT) manufacturing technology. The company has developed the IRO® platform, a proprietary, flexible manufacturing system that automates and standardizes CGT manufacturing in a closed platform, enabling therapy developers to scale from R&D to GMP and improve patient access to personalized treatments.PHILADELPHIA, PA